8-K/A
Current Report
Liminatus Pharma, Inc. Filed Acc 0001104659-25-055078
Acquisition or sale completed
- Item 2.01 Completion of acquisition or disposition of assets
From the SEC's structured data for this filing
Loading tm2516317d1_8ka.htm…